← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Brady grew FY2025 revenue 12.8% but net income, cash flow, and margins weakened, making the year more mixed than the sales line alone suggests.
The read at a glance✓ Audited against SEC data
- Business mix — Identification and safety productsNote
- Revenue — $1.51B, +12.8%OK
- Net income — $189.3M, -4.0%Watch
- FCF — $153.6M, -12.3%Watch
- FCF margin — 10.15%, -291 bpsWatch
- Insiders — 0 purchases / 10 salesWatch
- Accounting — Altman safe; Beneish clean; EQ safeOK
Business
Brady manufactures identification solutions and workplace safety products used to identify and protect premises, products, and people.
Where the revenue comes from
Fiscal 2026, as BRADY CORP reports it. History and quarterly detail are in the app.
- Americas & Asia$1.1B
- Europe & Australia$554.9M
Leadership changes
From BRADY CORP's own filings, the day they're filed.
- Russell R. Shaller · Chief Executive Officer · departureeff. 2026-06-08
- Christopher M. Hix · Directors · departureeff. 2026-03-31
- Thomas DeBruine · Chief Operating Officer · appointmenteff. 2024-06-03
Latest filings
- 10-K · Annual report2026-09-03
- 8-K · Company announcement2026-09-03
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-06-18
- 8-K · Company announcement2026-06-11
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about BRADY CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.